Effectiveness of Ginger in Reducing Inflammation Markers in Metabolic Diseases
Abstract
Metabolic diseases, including type 2 diabetes mellitus, obesity, metabolic syndrome, dyslipidemia, and non-alcoholic fatty liver disease, are commonly associated with chronic low-grade inflammation. Ginger (Zingiber officinale) contains bioactive compounds with anti-inflammatory and antioxidant properties that may support the management of these conditions. This literature review aimed to evaluate the effectiveness of ginger supplementation in reducing inflammatory markers in patients with metabolic diseases. Articles published between 2021 and 2026 were identified through PubMed, Scopus, ScienceDirect, SpringerLink, and Google Scholar using combinations of keywords related to ginger, metabolic diseases, and inflammatory markers. Articles were selected based on predefined inclusion criteria, and 15 studies were included in the final synthesis. Most studies reported that ginger supplementation reduced major inflammatory markers, particularly C-reactive protein, high-sensitivity C-reactive protein, tumor necrosis factor-alpha, and interleukin-6. Ginger also produced additional improvements in fasting blood glucose, glycated hemoglobin, insulin resistance, lipid profiles, body weight, body composition, and antioxidant status. These effects are primarily attributed to gingerol, shogaol, paradol, and zingerone, which inhibit nuclear factor-kappa B activation, suppress pro-inflammatory cytokine production, and strengthen antioxidant defenses. Overall, ginger shows potential as a safe, accessible, and economical complementary intervention for controlling inflammation in metabolic diseases. Nevertheless, further clinical trials with larger samples and standardized dosages, formulations, and intervention periods are needed to confirm its clinical effectivenes.
References
Al Dhaheri, A., Alkhatib, D., Feehan, J., Cheikh Ismail, L., Apostolopoulos, V., & Stojanovska, L. (2024). The effect of therapeutic doses of culinary spices in metabolic syndrome: A randomized controlled trial. Nutrients, 16(11). https://doi.org/10.3390/nu16111685
Asghari-Jafarabadi, M., & Khalili, L. (2022). The effect of ginger (Zingiber officinale) on improving blood lipids and body weight: A systematic review and multivariate meta-analysis of clinical trials. Current Pharmaceutical Design, 28(35), 2920–2943. https://doi.org/10.2174/1381612828666220926093847
Askari, G., & Aghajani, M. (2020). The effects of ginger supplementation on biomarkers of inflammation and oxidative stress in adults: A systematic review and meta-analysis of randomized controlled trials. Journal of Herbal Medicine, 22. https://doi.org/10.1016/j.hermed.2020.100364
Balderas-Peña, L. M. A., Sat-Muñoz, D., Mireles-Ramírez, M. A., Martínez-Herrera, B. E., Nava-Zavala, A. H., Cervantes-González, L. M., ... & Nuño-Guzmán, C. M. (2023). Influence of chronic low-grade inflammation (obesity) on the systemic inflammatory response. In Multisystem Inflammatory Syndrome-Natural History. IntechOpen. https://doi.org/10.5772/intechopen.1002764
Bellucci, E., Chiereghin, F., Pacifici, F., Donadel, G., De Stefano, A., Malatesta, G., ... & Pastore, D. (2023). Novel therapeutic approaches based on the pathological role of gut dysbiosis on the link between nonalcoholic fatty liver disease and insulin resistance. European review for medical and pharmacological sciences, 27(5), 1921-1944. https://doi.org/10.26355/eurrev_202303_31558
Chopra, D., Shukla, S., Rana, P., Kamar, M. D., Gaur, P., Bala, M., & Pathaniya, D. (2024). Overview of inflammation. In inflammation resolution and chronic diseases (pp. 1-18). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-97-0157-5_1
Cifuentes, M., Verdejo, H. E., Castro, P. F., Corvalan, A. H., Ferreccio, C., Quest, A. F., ... & Lavandero, S. (2024). Low-grade chronic inflammation: a shared mechanism for chronic diseases. Physiology. https://doi.org/10.1152/physiol.00021.2024
Clemente-Suárez, V. J., Beltrán-Velasco, A. I., Redondo-Flórez, L., Martín-Rodríguez, A., & Tornero-Aguilera, J. F. (2023). Global impacts of western diet and its effects on metabolism and health: a narrative review. Nutrients, 15(12), 2749. https://doi.org/10.3390/nu15122749
Ebrahimzadeh, A., Ebrahimzadeh, A., Mirghazanfari, S. M., Hazrati, E., Hadi, S., & Milajerdi, A. (2022). The effect of ginger supplementation on metabolic profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine, 65, 102802. https://doi.org/10.1016/j.ctim.2022.102802
Engin, A. (2024). Protein kinases in obesity, and the kinase-targeted therapy. Obesity and Lipotoxicity, 199-229. https://doi.org/10.1007/978-3-031-63657-8_7
Garg, S. S., Kushwaha, K., Dubey, R., & Gupta, J. (2023). Association between obesity, inflammation and insulin resistance: Insights into signaling pathways and therapeutic interventions. Diabetes research and clinical practice, 200, 110691. https://doi.org/10.1016/j.diabres.2023.110691
Ghoreishi, P. S., Shams, M., Nimrouzi, M., Zarshenas, M. M., Lankarani, K. B., Fallahzadeh Abarghooei, E., ... & Hashempur, M. H. (2024). The effects of ginger (Zingiber officinale Roscoe) on non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: A randomized double-blinded placebo-controlled clinical trial. Journal of Dietary Supplements, 21(3), 294-312. https://doi.org/10.1080/19390211.2023.2263788
Ghoreishi, P., Shams, M., Nimrouzi, M., Zarshenas, K., Lankarani, M., Fallahzadeh Abarghooei, E., Talebzadeh, M., & Hashempur, M. (2024). The effects of ginger (Zingiber officinale Roscoe) on non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: A randomized double-blinded placebo-controlled clinical trial. Journal of Dietary Supplements, 21(3), 294–312. https://doi.org/10.1080/19390211.2023.2263788
Hassanpour, S., Naghsh, N., Yazdanpanahi, N., & Talebian, N. (2024). Effect of zinc oxide nanocomposite and ginger extract on lipid profile, glucose, pancreatic tissue and expression of Gpx1 and Tnf-α genes in diabetic rat model. Molecular Biology Reports, 51(1), 11. https://doi.org/10.1007/s11033-023-08963-8
Khalilov, R., & Abdullayeva, S. (2023). Mechanisms of insulin action and insulin resistance. Advances in Biology & Earth Sciences, 8(2), 165. https://doi.org/10.1152/physrev.00063.2017
Khanna, D., Khanna, S., Khanna, P., Kahar, P., & Patel, B. M. (2022). Obesity: a chronic low-grade inflammation and its markers. Cureus, 14(2). https://doi.org/10.7759/cureus.22711
Latif, R., & Nawaz, T. (2026). Medicinal plants and human health: a comprehensive review of bioactive compounds, therapeutic effects, and applications. Phytochemistry Reviews, 25(3), 2299-2342. https://doi.org/10.1007/s11101-025-10194-7
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022). Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal transduction and targeted therapy, 7(1), 216. https://doi.org/10.1038/s41392-022-01073-0
Luo, L., Zhu, S., Akbari, A., & Tan, B. (2022). Ginger could improve gestational diabetes by targeting genes involved in nutrient metabolism, oxidative stress, inflammation, and the WNT/β-Catenin/GSK3β signaling pathway. Natural Product Communications, 17(12), 1934578X221141276. https://doi.org/10.1177/1934578X221141276
Mohammad, A., Falahi, E., Mohd Yusof, B., Hanipah, Z., Sabran, M., Mohamad Yusof, L., & Gheitasvand, M. (2021). The effects of the ginger supplements on inflammatory parameters in type 2 diabetes patients: A systematic review and meta-analysis of randomised controlled trials. Clinical Nutrition ESPEN, 46, 66–72. https://doi.org/10.1016/j.clnesp.2021.10.013
Morvaridzadeh, M., Fazelian, S., Agah, S., Khazdouz, M., Rahimlou, M., Agh, F., ... & Heshmati, J. (2020). Effect of ginger (Zingiber officinale) on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials. Cytokine, 135, 155224. https://doi.org/10.1016/j.cyto.2020.155224
Musazadeh, V., Morvaridi, M., Hosseini-Roknabadi, S. M., Mahmoudinezhad, M., Jafari, A., & Shidfar, F. (2026). Ginger supplementation and metabolic health: an umbrella review of meta-analyses of randomized trials. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/s13098-026-02150-y
Panyod, S., Wu, W. K., Hsieh, Y. C., Tseng, Y. J., Peng, S. Y., Chen, R. A., ... & Sheen, L. Y. (2024). Ginger essential oil prevents NASH progression by blocking the NLRP3 inflammasome and remodeling the gut microbiota-LPS-TLR4 pathway in mice. Nutrition & Diabetes, 14(1), 65. https://doi.org/10.1038/s41387-024-00306-1
Paudel, K., Orent, J., & Penela, O. (2025). Pharmacological properties of ginger (Zingiber officinale): What do meta-analyses say? A systematic review. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1619655
Püschel, G. P., Klauder, J., & Henkel, J. (2022). Macrophages, low-grade inflammation, insulin resistance and hyperinsulinemia: a mutual ambiguous relationship in the development of metabolic diseases. Journal of clinical medicine, 11(15), 4358. https://doi.org/10.3390/jcm11154358
Rafieipour, N., Gharbi, N., Rahimi, H., & Kohansal, A. (2024). Ginger intervention on body weight and body composition in adults: A GRADE-assessed systematic review and dose-response meta-analysis of 27 randomized controlled trials. Nutrition Reviews, 82(11), 1651–1665. https://doi.org/10.1093/nutrit/nuad149
Rahimlou, M., Yari, Z., Hekmatdoost, A., Alavian, S., & Keshavarz, S. (2026). Ginger supplementation in nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled pilot study. Hepatitis Monthly, 16(1). https://doi.org/10.5812/hepatmon.34897
Retiaty, F., Andarwulan, N., Palupi, N. S., Ernawati, F., Kazimierczak, R., & Średnicka-Tober, D. (2025). Contribution of Food, Energy, Macronutrients and Fiber Consumption Patterns to Obesity and Other Non-Communicable Disease Risks in the Indonesian Population. Nutrients, 17(9), 1459. https://doi.org/10.3390/nu17091459
Rjabi, S., Barbarz, H., Makhtoomi, M., Ahmadi, M., Najafi, H., Talakesh, S., Nouri, M., & Askarpour, M. (2025). Antioxidant and anti-inflammatory effects of ginger supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis of randomised controlled trials. Inflammopharmacology, 33(12), 7197–7216. https://doi.org/10.1007/s10787-025-01994-6
Rjabi, S., Seyedhatami, S. S., Makhtoomi, M., Ahmadi, M. R., Alimohamadi, S., Aliabadi, E., ... & Askarpour, M. (2025). Impact of ginger supplementation on obesity indices and Adipokine profiles in adults: A GRADE-based systematic review and dose-response meta-analysis of randomized controlled trials. Complementary therapies in medicine, 103260. https://doi.org/10.1016/j.ctim.2025.103260
Rostamkhani, H., Veisi, P., & Niknafs, B. (2023). The effect of Zingiber officinale on prooxidant-antioxidant balance and glycemic control in diabetic patients with ESRD undergoing hemodialysis: A double-blind randomized control trial. BMC Complementary Medicine and Therapies, 23, Article 52. https://doi.org/10.1186/s12906-023-03874-4
Schumacher, J., Mueller, V., Sousa, C., Peres, K., da Mata, I., Menezes, R., & Dal Bosco, S. (2024). The effect of oral supplementation of ginger on glycemic control of patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Clinical Nutrition ESPEN, 615–622. https://doi.org/10.1016/j.clnesp.2024.07.011
Shaik Mohamed Sayed, U. F., Moshawih, S., Goh, H. P., Kifli, N., Gupta, G., Singh, S. K., ... & Goh, B. H. (2023). Natural products as novel anti-obesity agents: insights into mechanisms of action and potential for therapeutic management. Frontiers in pharmacology, 14, 1182937. https://doi.org/10.3389/fphar.2023.1182937
Stanimirovic, J., Radovanovic, J., Banjac, K., Obradovic, M., Essack, M., Zafirovic, S., ... & Isenovic, E. R. (2022). Role of C‐reactive protein in diabetic inflammation. Mediators of inflammation, 2022(1), 3706508. https://doi.org/10.1155/2022/3706508
Tylutka, A., Walas, Ł., & Zembron-Lacny, A. (2024). Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis. Frontiers in immunology, 15, 1330386. https://doi.org/10.3389/fimmu.2024.1330386
Varra, F. N., Varras, M., Varra, V. K., & Theodosis-Nobelos, P. (2024). Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation mediating treatment options. Molecular medicine reports, 29(6), 95. https://doi.org/10.3892/mmr.2024.13219
Wang, R., Santos, J. M., Dufour, J. M., Stephens, E. R., Miranda, J. M., Washburn, R. L., ... & Shen, C. L. (2022). Ginger root extract improves GI health in diabetic rats by improving intestinal integrity and mitochondrial function. Nutrients, 14(20), 4384. https://doi.org/10.3390/nu14204384
Zhang, S., Kou, X., Zhao, H., Mak, K., Balijepalli, M., & Pichika, M. (2022). Zingiber officinale var. rubrum: Red ginger’s medicinal uses. Molecules, 27(3), 775. https://doi.org/10.3390/molecules27030775
Zhang, Y., Ju, J., Jiao, L., & Yang, B. (2023). Bioactive components of Chinese herbal medicines in the treatment of glucose and lipid metabolism disorders: evidence and potential mechanisms. Engineering, 29, 73-82. https://doi.org/10.1016/j.eng.2023.03.004
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023). The crucial role and mechanism of insulin resistance in metabolic disease. Frontiers in endocrinology, 14, 1149239. https://doi.org/10.3389/fendo.2023.1149239
Zhou, Q., Peng, Y., Chen, F., & Dai, J. (2023). Ginger supplementation for the treatment of non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials. African Health Sciences, 23(1), 614–621. https://doi.org/10.4314/ahs.v23i1.65
Copyright (c) 2026 Journal La Medihealtico
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
